Cargando…
An analysis of orphan medicine expenditure in Europe: is it sustainable?
BACKGROUND: Orphan medicinal product (OMP) prices are considered by some to be a challenge to the sustainability of healthcare expenditure. These concerns are compounded by the increasing number of OMPs receiving marketing authorisation (MA) annually. The aim of this study was to explore the sustain...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907352/ https://www.ncbi.nlm.nih.gov/pubmed/31829218 http://dx.doi.org/10.1186/s13023-019-1246-7 |